Palvella Therapeutics, Inc. (Nasdaq: PVLA) will take center stage at the 15th World Congress of Pediatric Dermatology in ...

The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.

Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...

There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.

The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...

Patient engagement through advisory boards, surveys, and listening sessions can help address industry challenges such as ...

Antihemophilic Factor binds factor IXa along with calcium and phospholipid. This complex converts factor X to factor Xa to ...

Initial results from the ongoing trial saw one patient achieving a complete response in the trial combining Tovecimig with ...

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...